Medicare Enrolled

Dr. Charukesi Chandrasekaran, MD

Psychiatry · Beaumont, TX
4450 HIGHLAND AVE, Beaumont, TX 77705
7133517360
Registered in NPPES since 2010
NPI: 1508173170 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chandrasekaran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chandrasekaran? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chandrasekaran

Dr. Charukesi Chandrasekaran is a psychiatry specialist in Beaumont, TX, with 16 years of NPI registration.

Between the years covered by Open Payments, Dr. Chandrasekaran received a total of $6,162 from 36 pharmaceutical and/or device companies across 382 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chandrasekaran is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration $6,162 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,162
Total received (2019-2024)
Avg $1,027/year across 6 years
Top 11% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
382
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,182
2023
$1,734
2022
$1,144
2021
$742
2020
$105
2019
$255

Payments by company (2024)

ABBVIE INC.
$472
Corium, LLC
$308
Lundbeck LLC
$170
Boston Scientific Corporation
$158
Neurocrine Biosciences, Inc.
$153
Otsuka America Pharmaceutical, Inc.
$138
Supernus Pharmaceuticals, Inc.
$116
Alkermes, Inc.
$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$89
Janssen Pharmaceuticals, Inc
$79
Takeda Pharmaceuticals U.S.A., Inc.
$78
Brainsway USA INC
$64
IDORSIA PHARMACEUTICALS US INC
$46
IRONSHORE PHARMACEUTICALS INC.
$44
Tris Pharma Inc
$44
Noven Therapeutics, LLC
$34
E.R. Squibb & Sons, L.L.C.
$21
Sage Therapeutics, Inc.
$21
Teva Pharmaceuticals USA, Inc.
$20
Neos Therapeutics, LP
$16
Axsome Therapeutics, Inc.
$13
Top 3 companies account for 43.5% of 2024 payments
All-time payments by company (2019-2024) ›
ABBVIE INC.
$701
AbbVie Inc.
$571
Corium, LLC
$430
Otsuka America Pharmaceutical, Inc.
$403
ITI, Inc.
$387
Lundbeck LLC
$351
Sunovion Pharmaceuticals Inc.
$320
Alkermes, Inc.
$271
Janssen Pharmaceuticals, Inc
$255
Takeda Pharmaceuticals U.S.A., Inc.
$234
Neurocrine Biosciences, Inc.
$224
Neos Therapeutics, LP
$216
Supernus Pharmaceuticals, Inc.
$199
Brainsway USA INC
$167
Ironshore Pharmaceuticals Inc.
$166
Boston Scientific Corporation
$158
Almatica Pharma LLC
$134
Merck Sharp & Dohme LLC
$120
Tris Pharma Inc
$113
Allergan Inc.
$89
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$89
IDORSIA PHARMACEUTICALS US INC
$81
Noven Therapeutics, LLC
$67
Allergan, Inc.
$67
JAZZ PHARMACEUTICALS INC.
$56
Bausch Health US, LLC
$48
IRONSHORE PHARMACEUTICALS INC.
$44
Merck Sharp & Dohme Corporation
$42
Axsome Therapeutics, Inc.
$27
Neuronetics, Inc.
$22
GRT US Holding, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$21
Sage Therapeutics, Inc.
$21
Teva Pharmaceuticals USA, Inc.
$20
Adlon Therapeutics L.P.
$15
Vertical Pharmaceuticals, LLC
$12
Top 3 companies account for 27.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BOTOX · Brainsway Deep TMS System · CAPLYTA · CITALOPRAM · COBENFY · COTEMPLA XR-ODT · Cotempla XR-ODT · Dyanavel XR · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY · QELBREE · QUVIVIQ · Qelbree · Qutenza · RELEXXII · REXULTI · SERTRALINE HCL · SPRAVATO · SUNOSI · Secuado · TRINTELLIX · Trintellix · UBRELVY · VIVITROL · VRAYLAR · Vivitrol · Xelstrym · ZURZUVAE
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Beaumont?
Compare psychiatrists in the Beaumont area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
17
County median income
$59,934
Nearest hospital to ZIP centroid (approximate)
BAPTIST BEAUMONT HOSPITAL
12.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chandrasekaran is a psychiatry specialist, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Chandrasekaran receive payments from pharmaceutical companies?
Yes. Dr. Chandrasekaran received a total of $6,162 from 36 companies across 382 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Chandrasekaran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →